U.S., Dec. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07294209) titled 'Low-Dose Tenecteplase for Acute Ischemic Stroke Treatment in Aging Patients' on Nov. 21.
Brief Summary: The DATE-AGING study is a prospective, multicenter, randomized controlled trial investigating low-dose tenecteplase in elderly patients with acute ischemic stroke. Its primary objective is to evaluate the safety and efficacy of low-dose tenecteplase in elderly patients within 4.5 hours of acute ischemic stroke onset.
Study Start Date: Dec. 26
Study Type: INTERVENTIONAL
Condition:
Acute Ischemic Stroke Patients
Intervention:
DRUG: low-dose tenecteplase intravenous thrombolysis
Subjects will be randomized to low-dose group or...